glutathione parkinsons disease therapy perlmutter Research progress on intranasal treatment for Parkinson's - Wen - 2024 - Neuroprotection Recent advances in natural products
Recent advances in natural products targeting synuclein aggregation or clearance in Parkinson's disease ScienceDirect Central nervous system uptake of intranasal glutathione in Parkinson's disease npj Parkinson's Disease Polysaccharide mediated in vivo cascade chemistry converts endogenous Cu(II) into copper nanoclusters as super nanozymes for Parkinson's disease treatment ScienceDirect PARKINSON'S DISEASE AS MULTIFACTORIAL OXIDATIVE NEURODEGENERATION: IMPLICATIONS FOR INTEGRATIVE MANAGEMENT Joel Perlmutter, MD Neurology Washington University in St. Louis
Pay in 4 interest-free payments of $5.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




